Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Shares of Terumo Corp. (OTCMKTS:TRUMYGet Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $13.99, but opened at $13.13. Terumo shares last traded at $13.57, with a volume of 4,472 shares trading hands.

Analyst Ratings Changes

Separately, Nomura upgraded shares of Terumo to a “hold” rating in a research note on Tuesday, February 24th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Read Our Latest Stock Analysis on TRUMY

Terumo Trading Down 2.5%

The business’s 50 day moving average price is $13.16 and its 200-day moving average price is $14.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07. The company has a market cap of $20.13 billion, a price-to-earnings ratio of 23.53 and a beta of 0.72.

Terumo (OTCMKTS:TRUMYGet Free Report) last released its quarterly earnings results on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Terumo had a return on equity of 9.01% and a net margin of 11.74%.The business had revenue of $1.94 billion for the quarter, compared to the consensus estimate of $1.82 billion.

Terumo Company Profile

(Get Free Report)

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

See Also

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.